コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sed by functional assays at both genetic and protein level.
2 t difference on methylome, transcriptome and protein level.
3 ically took several hours to manifest on the protein level.
4 d not just at the RNA level, but also at the protein level.
5 immune responses at the transcriptional and protein level.
6 ation of these pathways was confirmed at the protein level.
7 the absence of PsbQ' protein at genetic and protein level.
8 e amount of HDM2 protein correlates with HBx protein level.
9 hese pathways were validated at the mRNA and protein level.
10 phages led to significant reduction of STAT3 protein level.
11 immune response was verified at the mRNA and protein level.
12 some inhibitor partially restores the alpha1 protein level.
13 g PIF4 activity, through a reduction in PIF4 protein level.
14 rotein Vif (viral infectivity factor) at the protein level.
15 levels in HCEC, but had no effect on CYP27B1 protein levels.
16 ressed VitD Receptor (VDR), both on mRNA and protein levels.
17 and up-regulation of MT1-MMP at the gene and protein levels.
18 tial for DNA damage-induced increase of PTEN protein levels.
19 the decreased lysosomal gene expression and protein levels.
20 he left ventricles of RacET mice on mRNA and protein levels.
21 xpression of RANKL was evaluated at mRNA and protein levels.
22 of thyroid cancer cell lines at the mRNA and protein levels.
23 phenotypic information such as cell-surface protein levels.
24 aptic strength, dynamically regulates Tomo-1 protein levels.
25 protein cholesterol but increased C-reactive protein levels.
26 al hypertrophic phenotype by regulating IP3R protein levels.
27 decreased interleukin (IL)-4, IL10 and IL-13 protein levels.
28 nalysis Consortium at the peptide, gene, and protein levels.
29 N 1 (RCAN1) in the DRG at the transcript and protein levels.
30 nt in regulating cellular NEIL1 steady state protein levels.
31 , which degrade and suppress steady-state LT protein levels.
32 ecreased in Ct-infected ESC at both mRNA and protein levels.
33 antly reduced gene expression at the RNA and protein levels.
34 rts Gln into glutamate, at both the mRNA and protein levels.
35 olyubiquitination of TRAF2 and reduces TRAF2 protein levels.
36 the transcriptional, cellular, and secreted protein levels.
37 distribution and dramatically decreases MBP protein levels.
38 P-mutant mice show a reduction in alpha-SNAP protein levels.
39 ith GLUT5 mRNA levels but is linked to GLUT5 protein levels.
40 lysis were used to measure messenger RNA and protein levels.
41 increased IFN-lambda levels at the gene and protein levels.
42 mor necrosis factor (TNF)-alpha and IL-1beta protein levels.
43 ECD translation as the mechanism for reduced protein levels.
44 ARP-1 ubiquitination, which decreased PARP-1 protein levels.
45 or of cardiac hypertrophy by regulating IP3R protein levels.
46 these two sites and results in reduced Cbl-b protein levels.
47 bon concentration at both the transcript and protein levels.
48 nd ATF4 levels but robust increases in GRP78 protein levels.
49 e fine regulation at the transcriptional and protein levels.
50 Some had paresthesias (17%), elevated CSF protein level (13%), and other features sometimes consid
51 ed no evidence of decreasing AmCYAN1 and PMI protein levels across generations and no transgene silen
53 ession of these signature genes, at mRNA and protein levels, after small interfering RNA-mediated sil
55 ns leading to reduced, but not absent, P4HA1 protein level and C-P4H activity in dermal fibroblasts c
57 fection significantly upregulates the CaV2.1 protein level and enhances CaV2.1 protein stability.
59 f mice expressing EAAC1 leads to reduced D1R protein level and increased stereotyped movement executi
60 n vivo data; sirtinol decreased liver PEPCK1 protein level and prevented pyruvate-induced blood gluco
62 w that NiCl2 (Ni(II)) or hypoxia reduces the protein level and shortens the half-life of cytoplasmic
63 eased pyruvate dehydrogenase kinase 1 (PDK1) protein levels and a decreased pyruvate dehydrogenase en
64 Further experiments demonstrated that the protein levels and activities of oxidative phosphorylati
65 we show that activated CF MPhis have reduced protein levels and altered localization of the remaining
66 in ligase complex, reduces Aiolos and Ikaros protein levels and BAFF- and CD40L-induced proliferation
67 We find that histone H3.3 stabilizes DAXX protein levels and can affect DAXX-regulated gene expres
70 Y transcripts but dramatically decreased PSY protein levels and enzymatic activity, leading to reduce
72 (WF) and gingival biopsies were analyzed for protein levels and gene expression, respectively, of rel
74 decreased oxidative metabolism, whereas DLST protein levels and hence oxidative metabolism were parti
75 ations in DONSON substantially reduce DONSON protein levels and impair fork stability in cells from p
77 , but not mutagenized, C1qbp restored OXPHOS protein levels and mitochondrial enzyme activities in C1
78 alyses show progressive changes in ribosomal protein levels and mitochondrial function as early disea
79 ingdom), which reduced both serum C-reactive protein levels and peripheral blood monocyte secretion o
80 ion, while PKCzeta knockdown stabilizes RAGE protein levels and prevents ODN2006-mediated degradation
81 f age, wildtype mice showed altered synaptic protein levels and relatively superior cognitive perform
82 tion from Grn(-/-) mice normalizes lysosomal protein levels and rescues FTLD-related behavioral abnor
83 quitinase activity, BC-1471, decreases NALP7 protein levels and suppresses IL-1beta release after TLR
84 onstrated that these mutations reduce MRPS34 protein levels and the synthesis of OXPHOS subunits enco
85 K, also showed significantly decreased total protein levels and trafficking to the cell surface, whil
86 fied alterations of Her2 at the DNA, RNA and protein level, and demonstrate that Her2 relevance as a
87 y upregulated MTSS1 at the messenger RNA and protein level, and the accumulated protein was functiona
88 the dynamics of VSG coat replacement at the protein level, and the impact of this process on success
89 patic lipogenesis as judged by the activity, protein levels, and expression of several fatty acid syn
91 onsistently, T63 up-regulated RUNX2 mRNA and protein levels, and knockdown of RUNX2 reduced the osteo
92 l as XLKO Ocy454 cells, showed elevated SNX9 protein levels, and siRNA-mediated knockdown of SNX9 in
93 m lung cancer patients, both at the mRNA and protein levels, and that low caveolin-1 expression is as
94 isease, mutation details at the DNA, RNA and protein levels, and updates to the ZFIN single box searc
96 out mice and their upstream regulator, FoxO1 protein levels are decreased via proteasome-dependent de
100 emonstrate that E2F1 mRNA stability and E2F1 protein levels are reduced in cells lacking RALY express
101 present in spinal cord microglia, and RGS10 protein levels are suppressed in the spinal cord in a ne
102 accurate measurement of the extent to which proteins levels are adjusted to counter external stimuli
103 itatively characterized actin transcript and protein levels, as well as cellular phenotypes, in both
104 CA mutated tumors expressed higher p-AKT/AKT protein levels, both within primary (p < 0.001) and meta
105 1S heterozygotes showed no decrease of PINK1 protein levels but a sustained, significant reduction in
106 ins by impairing SIRT2 catalytic activity or protein levels but not its localization or binding with
107 ER stress induction led to a reduced ECD protein level, but this effect was not seen in PKR-like
108 sitivity and a reduction in SS18 and SMARCB1 protein levels, but an SSX18-SSX1 Delta71-78 fusion cont
110 ompanied by a 74% increase in cellular LFABP protein levels, but only when cells were exposed to 0.4
112 27A1 in prostate cancer was confirmed at the protein level by immunostaining for CYP27A1 in annotated
113 is well-known that Nrf2 is regulated at the protein level by proteasomal degradation via Kelch-like
114 ature, carbonic anhydrase XII (CA12), at the protein level by western blot and immunohistochemistry.
116 6 (hereafter CDK4/6) in vivo increases PD-L1 protein levels by impeding cyclin D-CDK4-mediated phosph
117 ed both intracellular and extracellular PGRN protein levels by increasing the translation rate of PGR
118 e expression by RNA sequencing and for serum protein levels by Luminex and enzyme-linked immunosorben
121 e profiling of glycosylation patterns at the protein level, by comparing originator and biosimilars m
122 Increasing or decreasing hypothalamic MANF protein levels causes hyperphagia or hypophagia, respect
123 ificantly higher highly sensitive-C-reactive protein levels compared to Controls (2.1 +/- 0.4 vs. 1.0
124 changes including reduced filaggrin mRNA and protein levels, compromised barrier function, marked ult
128 itinates GDU1 at cytosolic lysines, and GDU1 protein levels decreased upon co-expression with active,
139 t, in mice, liver mass, hepatocyte size, and protein levels follow a daily rhythm, whose amplitude de
142 t notably hemideletion females show elevated protein levels for ERK1 as well as the related kinase ER
143 gene replacements allowing for modulation of protein levels for otherwise lethal knockouts (KOs).
144 urgent unmet need to accurately quantify SMN protein levels for screening and therapeutic monitoring
146 ant decrease in synaptic gene expression and protein levels, glutamate neurotransmitter release, and,
147 uch research attention because its decreased protein level has been associated with poor prognosis of
149 show that Plk3 in turn suppresses the SIAH2 protein level in a kinase activity-dependent manner.
150 s) into Mtm1KO mice efficiently reduces DNM2 protein level in muscle and prevents the myopathy from d
151 y post-translational modifications at native protein level in order to correlate their influence on t
152 ld greater activity (323%) at any given FN3K protein level in the erythrocytes of the negative-GGap g
154 emonstrate a reduction of membralin mRNA and protein levels in Alzheimer's disease (AD) brain, the la
156 ies confirmed an increase in IL-17C mRNA and protein levels in cells infected with cagA-positive infe
159 f this study was to determine SGLT2 mRNA and protein levels in human and animal models of diabetic ne
160 sized that vitamin D deficiency alters TRAIL protein levels in human breast milk and mammary epitheli
162 d that integrated investigations of mRNA and protein levels in single cells allows comprehensive anal
163 Both treatments reduced the O-GlcNAcylated protein levels in SKO mice, and dapagliflozin successful
165 s, cases had significantly higher C-reactive protein levels in the discovery, replication, and pooled
167 phosphorylated cAMP-response element binding protein levels in the NAcSh that could account for the i
176 A oscillated with highest levels in G2 while protein levels increased throughout the cell cycle, peak
177 repress mTORC1 activity and maintain ApoB100 protein levels independently of Atf4 expression, whereas
179 somolysis and in vitro siRNA silencing ( 85% protein level knockdown) of the model gene luciferase ac
180 t hosts with normal CSF white blood cell and protein levels (</=5 cells/mm(3) and </=50 mg/dl, respec
182 ollected and analyzed histologically and TNF protein levels measured by enzyme-linked immunosorbent a
183 of 0.92 (reference range, 0.8-2.0), a urine protein level of 15 mg/dL (normal level, <20 mg/dL), a t
184 erence range, 79-125 mumol/L), a serum total protein level of 82 g/L (reference range, 66-81 g/L), a
185 We show that HCMV infection increases the protein level of a cellular trafficking factor, syntaxin
190 ed that sirtinol significantly decreased the protein level of PEPCK1, and was accompanied by the hype
192 ADCs, which include significant decreases in protein level of the tumor supressor genes such as PDCD4
193 in cells and a simultaneous increase in the protein levels of ALIX and ALG-2 are required to elicit
194 suppressing the transcriptional activity and protein levels of both full-length and splice-variant AR
195 diac histomorphology, glutathione levels and protein levels of cathepsin K and those associated with
199 ly attenuated after claudin-1 knockdown, and protein levels of extracellular signal-related kinase 1/
204 lation/inactivation, accompanied by enhanced protein levels of PDH kinases 1 and 3 (PDK1 and PDK3).
209 odel, and in both mouse models it normalized protein levels of several SCA2-related proteins expresse
210 t puerarin treatment increased both mRNA and protein levels of SIRT1 in podocytes and that puerarin l
213 tivation increases the abundance of mRNA and protein levels of the core autophagy-related (Atg) prote
216 nencapsulated siRNA against Tnf mRNA reduced protein levels of TNF in colon tissues, compared with mi
218 study used western blot analysis to compare protein levels of tyrosine hydroxylase (TH), glutamate d
221 conducted to investigate impacts of dietary protein levels on gut bacterial community and gut barrie
225 rofiles, hs-CRP (high-sensitivity C-reactive protein) levels, oxidative stress markers (glutathione a
230 e phenotypes, like changes in metabolite and protein levels, provide functional evidence to map disea
232 overexpressing the AhRR showed lower ERalpha protein levels, reduced responsiveness to estradiol, and
234 L) results in autoactivity, but lowering the protein levels restored its specific activation response
236 ell-type-specific gene expression and plasma protein levels sheds light on potential disease mechanis
237 vention strategies aimed at decreasing BACE1 protein levels should be regarded with caution, because
244 asome inhibitor MG132 largely restored c-Jun protein levels, suggesting that LT promotes degradation
245 schizophrenia group had higher TH and GAD67 protein levels than controls (an increase of 69.6%, P=0.
246 s of VSMC and to understand how variation in protein levels that arise due to diabetes contribute to
247 l muscle, and white adipose tissue PPARdelta protein levels that may, in part, explain the observed l
248 lpha (Calpha) expression both at the RNA and protein levels that were also seen in human patients wit
250 exhibited diminished STAT1 and NF-kappaB Rel protein levels, the essential inducers of iNOS in myeloi
252 tally validated that miR-210 regulated GPD1L protein level through direct interaction with its mRNA t
253 htly controlled at the mRNA level and at the protein level through endocytosis and degradation trigge
254 sults, complete blood cell count, C-reactive protein levels, thyroid-stimulating hormone levels, and
255 n Grn(-/-) brain at both transcriptional and protein levels, TMEM106B deficiency causes reduction in
256 ild-type troponin complex corrected troponin protein levels to 83% of controls in the TNNI3p.98trunc
257 igo extension reaction (OER), which converts protein levels to DNA levels, with reverse transcription
258 ence of a feedback circuit to match synaptic protein levels to the transport capacity of the axon.
260 bosome loading onto Ccnb2 mRNA and Cyclin B2 protein level undergo minimal changes during meiotic ree
262 xplained up to 66% of interindividual plasma protein-level variation and, on average, accounted for 3
264 ations of C1572 markedly reduced c-MYC (MYC) protein levels via a proteasome-dependent mechanism.
265 patic glucose production by regulating FoxO1 protein levels via proteasome-dependent degradation and,
266 hese findings indicate that LT reduces c-Jun protein levels via two distinct mechanisms, thereby inhi
269 ince genome alteration are manifested at the protein level, we integrated protein and mRNA data of ov
270 l consequences of these FN1 mutations on the protein level, we introduced three disease-associated mi
271 e-rich C-kinase substrate (MARCKS) and LAMC2 protein level were increased with AKT1 inhibition, and M
272 sis-related genes and the circulating ADIPOQ protein level were lower in Brd4 heterozygous mice than
276 Substantia nigra, putamen, and cortical p11 protein levels were assessed in postmortem brain samples
281 stmortem findings, we found that Kal9-P2255T protein levels were higher than those of wild-type Kal9
284 enhanced autophagy initiation, ULK1 mRNA and protein levels were increased in STAT1-deficient cells.
291 ygen consumption ratio (OCR) and higher VDAC protein levels when compared to WT and Myd88(-/-) cells.
292 increases TDP-43 toxicity, aggregation, and protein levels, whereas enhancing endocytosis reverses t
293 neutrophilic asthma and with sputum IL-1beta protein levels, whereas eosinophilic asthma was associat
294 the increased lysosomal gene expression and protein levels, while PGRN overexpression led to the dec
295 RTN3 deficiency causes elevation of BACE1 protein levels, while RTN1 deficiency shows no obvious e
296 h findings in other models of altered TBC1D1 protein levels, whole-animal and ex vivo skeletal muscle
298 aize is supported by comparisons of relative protein levels with teosinte as well as by quantitative
299 t associations between type I IFN-alpha/beta protein levels with the DNA methylation status as well a
300 ases basal and gamma irradiation-induced p21 protein levels without affecting p21 mRNA expression.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。